Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Cobra To Manufacture GenVec Drug Candidate | Contract Pharma

What are you searching for?

Sign in
Breaking News

Cobra To Manufacture GenVec Drug Candidate

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Cobra Biomanufacturing has entered into a manufacturing development agreement with GenVec, Inc. for TNFerade, GenVec’s lead candidate for pancreatic cancer. The agreement includes technology transfer, scale-up, and validation of the manufacturing process for the compound through cGMP consistency lots that will be produced at Cobra’s facility in Oxford, UK.  
    
“GenVec selected Cobra based upon their expertise in viral manufacturing and the experience of key staff members with commercial biopharmaceutical products.  Activities under this agreement will establish a clear path for the submission of the chemistry, manufacturing, and controls (CMC) portion of a biological license application for TNFerade as GenVec works towards the completion of our current Phase III clinical trial,” said Dr. Bryan Butman, GenVec’s senior vice president of Vector Operations.  
    
“We are delighted to work with GenVec on this exciting project. TNFerade has demonstrated great potential for the treatment of pancreatic cancer,” added Simon Saxby, Cobra’s chief operating officer. “This agreement will leverage Cobra’s significant experience manufacturing recombinant adenovirus under cGMP conditions.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics